Remove regulatory
article thumbnail

Prior authorization and other regulatory burdens have increased since last year, practices tell MGMA

Fierce Healthcare

Nine in 10 polled medical practices say their regulatory burden has increased over the past year with prior authorization, audits and appeals, the Medicare Quality Payment Program (QPP) and require | The latest annual poll of practices' regulatory burden outlined prior authorization, audits and appeals, Medicare QPP and other leading pain points (..)

Medicare 355
article thumbnail

Elevance, BCBSLA pause $2.5B merger amid regulatory scrutiny

Health Care Dive

The health insurers originally expected their merger to close before the end of 2023, but have hit snags receiving the regulatory green light in Louisiana.

263
263
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

JAPAC Drug Development: Navigating Safety & Regulatory Requirements

HIT Consultant

Director of Regulatory Affairs and Drug Development Solutions, IQVIA Asia Pacific The biopharmaceutical market within the Japan and Asia-Pacific (JAPAC) region has grown consistently since 2010, specifically for emerging biopharmas (EBPs). Japan’s PMDA has many safety and regulatory distinctions.

article thumbnail

Healthcare dealmaking 'resilient' despite regulatory, economic headwinds: PwC

Fierce Healthcare

Even in the face of substantial headwinds, dealmaking in the healthcare industry hasn't fallen off, according to a new analysis from PwC. Even in the face of substantial headwinds, dealmaking in the healthcare industry hasn't fallen off, according to a new analysis from PwC.

article thumbnail

CVS expects to close Oak Street Health deal by July as acquisition clears regulatory obstacle

Fierce Healthcare

CVS expects to close Oak Street Health deal by July as acquisition clears regulatory obstacle hlandi Fri, 03/31/2023 - 12:05

240
240
article thumbnail

Emerging regulatory standards are paving the way for a new era: Unified experiences will be healthcare’s future

Health Care Dive

The impending changes to prior authorization processing aren’t minor, and they aren’t the only types of regulatory transformation that healthcare organizations will need to navigate in the months and years to come.

article thumbnail

Psychedelic Lobbying and Regulatory Capture

Bill Of Health

By Vincent Joralemon Psychedelic companies and advocacy groups are spending substantial resources to influence regulatory policy, shaping what the blossoming field will ultimately cohere into. When that leads to undue influence, the result is known as “regulatory capture.” What is Regulatory Capture?